11
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Sustained biochemical control in patients with acromegaly treated with lanreotide depot 120 mg administered every 4 weeks, or an extended dosing interval of 6 or 8 weeks: a pharmacokinetic approach

, , , &
Pages 79-84 | Published online: 14 Dec 2012